Autres avocats qui pourraient vous intéresser
Chris specialises in complex cross-border and UK private equity investments, acquisitions, disposals, corporate restructurings and joint ventures. He has particular expertise in advising on minority and growth capital investments.
Chris acts for clients including private equity sponsors, founders, management teams and corporates. He also has significant experience in acting for privately wealthy individuals and family offices and for US-based clients investing in the UK.
Clients say Chris is able to rapidly assess complex matters and provide the most pragmatic solution. Opposing counsel describe him as collaborative, creative and commercial.
He advises clients across a broad range of sectors, but particularly in the financial services, life sciences and energy sectors. He is especially interested in the cross-over between these sectors and innovative technological solutions.
Chris was listed by Law.com as one of the best 25 young private equity lawyers in the UK and Europe in 2022 and co-led the team that won Life Sciences Team of the Year at the British Legal Awards 2022. He was listed as a key lawyer in Taylor Wessing's M&A team in Legal 500 in 2021. He also advised on the establishment of The British Business Bank, for which the in-house team won Chambers In-house Public Law Team of the year for the innovative and agile manner the British Business Bank was set up.
|Since 2021||Partner, Taylor Wessing|
|2017 - 2021||Senior Associate, Stephenson Harwood|
|2011 - 2017||Associate, Slaughter and May|
|2009 - 2011||Trainee, Slaughter and May|
|2011||Admitted as a lawyer, England and Wales|
|2008 - 2009||BPP Law School, LPC|
|2007 - 2008||Oxford Brookes, GDL|
|2007||Masters in Medieval History, Lincoln College, University of Oxford|
|2006||BA Hons, Modern History, Lincoln College, University of Oxford and Princeton University|
|2003 - 2006||Oxford University, BA History|
Actualités et publications récentes
Recognition for our expertise as Life Sciences Team of the Year
par plusieurs auteurs
Chris Cowley listed in Law.com's Private Equity Rising Stars 2022
par Chris Cowley
Advising Gallagher on Devitt acquisition
par plusieurs auteurs
Advising Apollo Therapeutics on $145 million financing
par Andrew Edge et Chris Cowley
Dr. Peter Hellich
Dr. Armin Bartsch